Detalhe da pesquisa
1.
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
Brain
; 147(6): 2144-2157, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38667631
2.
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges.
Clin Chem
; 70(3): 538-550, 2024 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431278
3.
Determinants of Plasma Alzheimer's Disease Biomarker Use by Primary Care Providers and Dementia Specialists.
J Gen Intern Med
; 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38169023
4.
Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts.
Alzheimers Dement
; 20(5): 3305-3321, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539269
5.
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors.
Alzheimer Dis Assoc Disord
; 37(4): 282-289, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824581
6.
New horizons in understanding oral health and swallowing function within the context of frailty.
Age Ageing
; 52(2)2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735843
7.
Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials.
Alzheimers Dement
; 19(9): 4270-4275, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450489
8.
Alzheimer's Disease - Anti-Amyloid Medications, Early Detection, and Screening.
N Engl J Med
; 390(10): e22, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446673
9.
Alzheimer's Disease - Managing Stages of Dementia.
N Engl J Med
; 390(12): e29, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507749
10.
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results.
Alzheimer Dis Assoc Disord
; 36(2): 125-132, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125399
11.
Comparing emergency department use among individuals with varying levels of cognitive impairment.
BMC Geriatr
; 22(1): 382, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501721
12.
Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample.
J Genet Couns
; 31(4): 989-997, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460578
13.
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
Alzheimers Dement
; 18(10): 1969-1979, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213786
14.
Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults.
Alzheimers Dement
; 18(1): 65-76, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984184
15.
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
Brain
; 143(1): 320-335, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31886494
16.
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center.
Alzheimers Dement
; 15(12): 1533-1545, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601516
17.
Hypertension and obesity moderate the relationship between ß-amyloid and cognitive decline in midlife.
Alzheimers Dement
; 15(3): 418-428, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367828
18.
Ushering in a New Era of Alzheimer Disease Therapy.
JAMA
; 330(6): 503-504, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459123
19.
A comparison of story-recall metrics to predict hippocampal volume in older adults with and without cognitive impairment.
Clin Neuropsychol
; 38(2): 453-470, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349970
20.
Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Neurobiol Aging
; 133: 87-98, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925995